As of November 2024 ImmunoPrecise Antibodies has a market cap of A$19.82 Million. This makes ImmunoPrecise Antibodies the world's 9731th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 15th, 2024 the market cap of ImmunoPrecise Antibodies was reported to be: